Retrospective Analysis of Bevacizumab in Combination with Ifosfamide, Carboplatin, and Etoposide in Patients with Second Recurrence of Glioblastoma

Bevacizumab has been reported to be effective for recurrent glioblastoma. In our hospital, ifosfamide, carboplatin, etoposide (ICE) is the second-line chemotherapy for first recurrence of glioblastoma after temozolomide failure. In the present analysis, we retrospectively investigated the feasibilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Arakawa, Yoshiki, Mizowaki, Takashi, Murata, Daiki, Fujimoto, Koichi, Kikuchi, Takayuki, Kunieda, Takeharu, Takahashi, Jun C., Takagi, Yasushi, Miyamoto, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2013
Materias:
Special Theme Topic: Treatment of Malignant Brain Tumor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508722/
https://www.ncbi.nlm.nih.gov/pubmed/24140770
http://dx.doi.org/10.2176/nmc.oa2013-0211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508722/
https://www.ncbi.nlm.nih.gov/pubmed/24140770
http://dx.doi.org/10.2176/nmc.oa2013-0211

Ejemplares similares